Patents by Inventor Peter Stacpoole

Peter Stacpoole has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for monitoring and preventing clinically significant ketone levels in patients receiving dichloroacetate co-administered with a carbohydrate restricted diet
    Patent number: 12768840
    Abstract: Methods of controlling unhealthy levels of beta-hydroxybutyrate during dichloroacetate administration by managing diet are disclosed.
    Type: Grant
    Filed: May 23, 2025
    Date of Patent: October 20, 2026
    Assignees: SAOL INTERNATIONAL DEVELOPMENT LTD., UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
    Inventors: David Penake, Susan Clement, John Devane, Sharon Hamm, Peter Stacpoole, Richard Wagner
  • METHOD FOR MONITORING AND PREVENTING CLINICALLY SIGNIFICANT KETONE LEVELS IN PATIENTS RECEIVING DICHLOROACETATE CO-ADMINISTERED WITH A CARBOHYDRATE RESTRICTED DIET
    Publication number: 20250369974
    Abstract: Methods of controlling unhealthy levels of beta-hydroxybutyrate during dichloroacetate administration by managing diet are disclosed.
    Type: Application
    Filed: May 23, 2025
    Publication date: December 4, 2025
    Applicants: SAOL INTERNATIONAL DEVELOPMENT LTD., University of Florida Research Foundation, Incorporated
    Inventors: David PENAKE, Susan CLEMENT, John DEVANE, Sharon HAMM, Peter STACPOOLE, Richard WAGNER
  • METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY
    Publication number: 20250223628
    Abstract: Methods of improving survival and eliminating treatment-limiting toxicities of dichloroacetate (DCA) in patients with pyruvate dehydrogenase complex deficiency (PDCD).
    Type: Application
    Filed: January 7, 2025
    Publication date: July 10, 2025
    Applicants: SAOL INTERNATIONAL DEVELOPMENT LTD., University of Florida Research Foundation, Incorporated
    Inventors: David PENAKE, Sharon HAMM, Susan CLEMENT, John DEVANE, Peter STACPOOLE
  • PDK inhibitor compounds and methods of use thereof
    Patent number: 8492344
    Abstract: The invention relates to methods of treating or preventing acquired or congenital mitochondrial diseases or disorders, including treating cell proliferation related disorders or diseases, such as cancer. The invention further relates to pharmaceutical compositions for treating such disorders or diseases.
    Type: Grant
    Filed: September 1, 2009
    Date of Patent: July 23, 2013
    Assignee: University of Florida Research Foundation
    Inventors: David A. Ostrov, Peter Stacpoole, Arun Srivastava
  • PDK INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF
    Publication number: 20120004284
    Abstract: The invention relates to methods of treating or preventing acquired or congenital mitochondrial diseases or disorders, including treating cell proliferation related disorders or diseases, such as cancer. The invention further relates to pharmaceutical compositions for treating such disorders or diseases.
    Type: Application
    Filed: September 1, 2009
    Publication date: January 5, 2012
    Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION
    Inventors: David A. Ostrov, Peter Stacpoole, Arun Srivastava